SMARCA4 and neoplasm: This evidence supports the notion that the putative tumour suppressor function associated with SMARCA4 loss‐of‐function mutations in human and mouse neoplasms is tissue and cell type‐dependent and further does not predispose cells of the mature T‐cell lineage to oncogenic transformation.